Attachment A_60 Day FRN

khammond on DSKJM1Z7X2PROD with NOTICES

Federal Register / Vol. 89, No. 86 / Thursday, May 2, 2024 / Notices
individuals with and without
disabilities on its advisory committees
and, therefore encourages nominations
of appropriately qualified candidates
from these groups. A nominee may
either be self-nominated or nominated
by an organization. In addition, FDA is
requesting that any industry
organizations interested in participating
in the selection of a nonvoting
representative of the interests of the
tobacco growers industry to serve on the
TPSAC, notify FDA in writing.
Nominations will be accepted for either
the representative to serve on TPSAC or
for the selection group effective with
this notice.
DATES: Nomination materials for
prospective candidates should be sent to
FDA by June 3, 2024. Concurrently, any
industry organization interested in
participating in the selection of an
appropriate nonvoting member to
represent the interests of the tobacco
growers industry must send a letter
stating that interest to FDA by June 3,
2024 (see sections I and II of this
document for further details).
ADDRESSES: All nominations for
nonvoting representatives of the
interests of the tobacco growers industry
may be submitted electronically by
accessing the FDA Advisory Committee
Membership Nomination Portal: https://
www.accessdata.fda.gov/scripts/
FACTRSPortal/FACTRS/index.cfm.
All statements of interest from
industry organizations interested in
participating in the selection process of
nonvoting representatives of the
interests of the tobacco growers industry
nomination should be sent to Serina
Hunter-Thomas (see FOR FURTHER
INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT:
Serina Hunter-Thomas, Office of
Science, Center for Tobacco Products,
Food and Drug Administration,
Document Control Center, Bldg. 71, Rm.
G335, 10903 New Hampshire Ave.,
Silver Spring, MD 20993–0002, 1–877–
287–1373 (choose Option 5), email:
Serina.Hunter-Thomas@fda.hhs.gov.
Information about becoming a
member of an FDA advisory committee
can also be obtained by visiting FDA’s
website at: http://www.fda.gov/
AdvisoryCommittees/default.htm.
SUPPLEMENTARY INFORMATION: FDA is
requesting nominations for a nonvoting
representative of the interests of the
tobacco growers industry on the TPSAC.
I. General Description of the Committee
Duties
The TPSAC advises the Commissioner
of Food and Drugs (the Commissioner)
or designee in discharging

VerDate Sep<11>2014

17:14 May 01, 2024

Jkt 262001

responsibilities related to the regulation
of tobacco products. The TPSAC
reviews and evaluates safety,
dependence, or health issues relating to
tobacco products and provides
appropriate advice, information, and
recommendations to the Commissioner.
II. Nomination Procedure
Individuals may self-nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
representative of the interests of the
tobacco growers industry. Nominations
must include a current re´sume´ or
curriculum vitae for each nominee,
including current business address and/
or home address, telephone number,
and email address if available.
Nominations must specify the advisory
committee for which the nominee is
recommended. Nominations must also
acknowledge that the nominee is aware
of the nomination unless selfnominated. The nomination should be
sent to the FDA Advisory Committee
Membership Nomination Portal (see
ADDRESSES) within 30 days of
publication of this document (see
DATES). FDA will forward all
nominations to the organizations
expressing interest in participating in
the selection process. (Persons who
nominate themselves as nonvoting
industry representatives will not
participate in the selection process.)
III. Selection Procedure
The Agency is also seeking names of
organizations to participate in the
selection of the nonvoting
representative of the interests of the
tobacco growers industry. Any industry
organization interested in participating
in the selection of an appropriate
nonvoting member to represent growers
industry interests should send a letter
stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT)
within 30 days of publication of this
document (see DATES). Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest in participating in
the selection group, attaching a
complete list of all organizations
participating in selection; and a list of
all nonvoting nominees along with their
current re´sume´s. The letter will also
state that it is the responsibility of the
interested organizations on the selection
group to confer with one another and to
select a candidate and an alternative as
backup, within 60 days after the receipt
of the FDA letter, to serve as the
nonvoting member to represent growers
industry interests for the TPSAC. The
interested organizations are not bound
by the list of nominees in selecting a

PO 00000

Frm 00069

Fmt 4703

Sfmt 4703

35841

candidate. However, if no individual is
selected within 60 days, the
Commissioner will select the nonvoting
member to represent growers industry
interests.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. 1001 et seq.) and part 14, relating
to advisory committees.
Dated: April 29, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–09532 Filed 5–1–24; 8:45 am]
BILLING CODE 4164–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: The Maternal,
Infant, and Early Childhood Home
Visiting Program Quarterly
Performance Report
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:

In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than July 1, 2024.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Joella Roland, the HRSA
Information Collection Clearance
Officer, at (301) 443–3983.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
The Maternal, Infant, and Early
SUMMARY:

E:\FR\FM\02MYN1.SGM

02MYN1

35842

Federal Register / Vol. 89, No. 86 / Thursday, May 2, 2024 / Notices

Childhood Home Visiting Program
Quarterly Performance Report OMB No.
0906–0016—Revision.
Abstract: This request is for continued
approval of the Maternal, Infant, and
Early Childhood Home Visiting
(MIECHV) Program Quarterly
Performance Report. The MIECHV
Program is administered by the
Maternal and Child Health Bureau
(MCHB) within HRSA in partnership
with the Administration for Children
and Families, and provides support to
all 56 States and jurisdictions, as well
as Tribes and Tribal organizations.
Through a needs assessment, States,
jurisdictions, Tribes, and Tribal
organizations identify target populations
and select the home visiting service
delivery model(s) that best meet their
needs. In response to awardee feedback,
HRSA is proposing the following
revisions to the data collection forms to

reduce administrative burden related to
this performance report:
• Form 4, Table A.2: Remove Column
D: Zip Codes
• Form 4, Definition of Key Terms:
Update definitions for Table A.2
• Form 4: Remove Section B
Need and Proposed Use of the
Information: HRSA uses quarterly
performance information to demonstrate
program accountability and
continuously monitor and provide
oversight to MIECHV Program awardees.
The information is also used to provide
quality improvement guidance and
technical assistance to awardees and
help inform the development of early
childhood systems at the national, State,
and local level. HRSA is seeking to
remove collection of a variable and
update key terms given this deletion.
Likely Respondents: MIECHV Program
awardees that are States, jurisdictions,

and, where applicable, nonprofit
organizations providing home visiting
services within States.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Total
responses

Average
burden per
response
(in hours)

Total
burden
hours

Form 4: Section A—Quarterly Performance Report ............................

56

4

224

21

4,704

Total ..............................................................................................

56

........................

224

....................

4,704

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–09533 Filed 5–1–24; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: COVID–19
Provider Relief Programs Single and
Commercial Audits and Delinquent
Audit Reporting Submission Activities,
Office of Management and Budget No.
0906–0083—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:

In compliance with the
requirement to provide opportunity for
public comment on proposed data
collection projects per the Paperwork
Reduction Act of 1995, HRSA
announces plans to submit an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB). Prior
to submitting the ICR to OMB, HRSA
seeks comments from the public
regarding the burden estimate, below, or
any other aspect of the ICR.

SUMMARY:

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Form name

VerDate Sep<11>2014

17:14 May 01, 2024

Jkt 262001

PO 00000

Frm 00070

Fmt 4703

Sfmt 4703

Comments on this ICR should be
received no later than July 1, 2024.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Joella Roland, the HRSA
Information Collection Clearance
Officer, at (301) 443–3983.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
COVID–19 Provider Relief Programs
Single and Commercial Audits and
Delinquent Audit Reporting Submission
Activities, OMB No. 0906–0083—
Extension.
Abstract: The Coronavirus Aid, Relief,
and Economic Security Act (Pub. L.
116–136); the Paycheck Protection
Program and Health Care Enhancement
Act (Pub. L. 116–139); the Coronavirus
Response and Relief Supplemental
Appropriations Act (Pub. L. 116–260);
the Families First Coronavirus Response
DATES:

E:\FR\FM\02MYN1.SGM

02MYN1